Home
Storia in 3 fonti
Hims & Hers shares surge 50% after Novo Nordisk drops patent infringement case over compounded weight loss drugs
Novo dropped its patent-infringement case against telehealth provider Hims & Hers after the companies agreed that Hims would sell Novo's branded medicines.
- ·
cincodias.elpais.com
Hims & Hers sube con fuerza en Bolsa gracias a un acuerdo con Novo Nordisk que pone fin a su disputa pública
Las acciones de la empresa estadounidense ganan más del 40%
- ·
cnbc.com
Hims & Hers shares surge 50% after Novo Nordisk drops patent infringement case over compounded weight loss drugs
Novo dropped its patent-infringement case against telehealth provider Hims & Hers after the companies agreed that Hims would sell Novo's branded medicines.
- ·
upi.com
Hims & Hers stock jumps after Novo Nordisk drops lawsuit - UPI.com
Shares of Hims & Hers jumped as much as 55% Monday after Novo Nordisk announced it is dropping its lawsuit over Ozempic and Wegovy copycat drugs.